ResMed Current Ratio 2010-2025 | RMD
Current and historical current ratio for ResMed (RMD) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. ResMed current ratio for the three months ending March 31, 2025 was 3.41.
| ResMed Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $3.21B | $0.94B | 3.41 |
| 2024-12-31 | $2.84B | $0.85B | 3.33 |
| 2024-09-30 | $2.64B | $0.90B | 2.92 |
| 2024-06-30 | $2.36B | $0.91B | 2.59 |
| 2024-03-31 | $2.35B | $0.77B | 3.04 |
| 2023-12-31 | $2.38B | $0.76B | 3.11 |
| 2023-09-30 | $2.31B | $0.77B | 2.99 |
| 2023-06-30 | $2.37B | $0.76B | 3.12 |
| 2023-03-31 | $2.34B | $0.76B | 3.07 |
| 2022-12-31 | $2.33B | $0.73B | 3.17 |
| 2022-09-30 | $2.03B | $0.69B | 2.94 |
| 2022-06-30 | $1.93B | $0.69B | 2.80 |
| 2022-03-31 | $1.70B | $0.67B | 2.55 |
| 2021-12-31 | $1.55B | $0.62B | 2.49 |
| 2021-09-30 | $1.59B | $0.62B | 2.54 |
| 2021-06-30 | $1.58B | $0.91B | 1.73 |
| 2021-03-31 | $1.47B | $0.88B | 1.67 |
| 2020-12-31 | $1.45B | $0.58B | 2.51 |
| 2020-09-30 | $1.54B | $0.59B | 2.61 |
| 2020-06-30 | $1.52B | $0.60B | 2.53 |
| 2020-03-31 | $1.47B | $0.55B | 2.67 |
| 2019-12-31 | $1.30B | $0.50B | 2.60 |
| 2019-09-30 | $1.16B | $0.55B | 2.11 |
| 2019-06-30 | $1.15B | $0.56B | 2.06 |
| 2019-03-31 | $1.10B | $0.46B | 2.38 |
| 2018-12-31 | $1.06B | $0.44B | 2.44 |
| 2018-09-30 | $1.09B | $0.42B | 2.58 |
| 2018-06-30 | $1.07B | $0.51B | 2.09 |
| 2018-03-31 | $1.60B | $0.46B | 3.48 |
| 2017-12-31 | $1.75B | $1.36B | 1.29 |
| 2017-09-30 | $1.66B | $0.35B | 4.72 |
| 2017-06-30 | $1.64B | $0.36B | 4.57 |
| 2017-03-31 | $1.61B | $0.34B | 4.77 |
| 2016-12-31 | $1.52B | $0.68B | 2.23 |
| 2016-09-30 | $1.48B | $0.62B | 2.38 |
| 2016-06-30 | $1.42B | $0.64B | 2.23 |
| 2016-03-31 | $1.40B | $0.29B | 4.89 |
| 2015-12-31 | $1.35B | $0.27B | 5.09 |
| 2015-09-30 | $1.53B | $0.26B | 5.96 |
| 2015-06-30 | $1.41B | $0.27B | 5.28 |
| 2015-03-31 | $1.55B | $0.26B | 6.06 |
| 2014-12-31 | $1.56B | $0.26B | 6.00 |
| 2014-09-30 | $1.54B | $0.25B | 6.04 |
| 2014-06-30 | $1.56B | $0.27B | 5.77 |
| 2014-03-31 | $1.56B | $0.25B | 6.33 |
| 2013-12-31 | $1.56B | $0.24B | 6.44 |
| 2013-09-30 | $1.56B | $0.61B | 2.55 |
| 2013-06-30 | $1.45B | $0.57B | 2.52 |
| 2013-03-31 | $1.58B | $0.58B | 2.72 |
| 2012-12-31 | $1.53B | $0.25B | 6.09 |
| 2012-09-30 | $1.45B | $0.25B | 5.73 |
| 2012-06-30 | $1.36B | $0.25B | 5.38 |
| 2012-03-31 | $1.33B | $0.26B | 5.15 |
| 2011-12-31 | $1.25B | $0.23B | 5.46 |
| 2011-09-30 | $1.14B | $0.23B | 5.06 |
| 2011-06-30 | $1.29B | $0.21B | 6.19 |
| 2011-03-31 | $1.20B | $0.19B | 6.28 |
| 2010-12-31 | $1.15B | $0.25B | 4.64 |
| 2010-09-30 | $1.07B | $0.29B | 3.73 |
| 2010-06-30 | $0.99B | $0.31B | 3.15 |
| 2010-03-31 | $1.03B | $0.33B | 3.17 |
| 2009-12-31 | $0.93B | $0.24B | 3.86 |
| 2009-09-30 | $0.94B | $0.29B | 3.22 |
| 2009-06-30 | $0.85B | $0.27B | 3.17 |
| 2009-03-31 | $0.73B | $0.23B | 3.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.786B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.372B | 27.70 |
| Boston Scientific (BSX) | United States | $149.971B | 37.54 |
| Stryker (SYK) | United States | $142.469B | 29.79 |
| EssilorLuxottica (ESLOY) | France | $128.310B | 0.00 |
| Medtronic (MDT) | Ireland | $109.952B | 15.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.265B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.015B | 26.80 |
| GE HealthCare Technologies (GEHC) | United States | $32.917B | 15.63 |
| Agilent Technologies (A) | United States | $32.815B | 21.39 |
| Terumo (TRUMY) | Japan | $26.606B | 34.56 |
| Koninklijke Philips (PHG) | Netherlands | $21.242B | 14.90 |
| Insulet (PODD) | United States | $21.238B | 83.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.915B | 11.51 |
| Baxter (BAX) | United States | $15.293B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.517B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.313B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $5.465B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.133B | 18.46 |
| Perrigo (PRGO) | Ireland | $3.618B | 9.17 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.366B | 15.33 |
| ICU Medical (ICUI) | United States | $3.165B | 23.34 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.916B | 13.18 |
| LeMaitre Vascular (LMAT) | United States | $1.846B | 41.26 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.335B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.144B | 11.62 |
| Neogen (NEOG) | United States | $1.083B | 13.86 |
| Green Thumb Industries (GTBIF) | United States | $1.059B | 23.81 |
| BioLife Solutions (BLFS) | United States | $1.022B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.971B | 12.41 |
| InMode (INMD) | Israel | $0.843B | 8.50 |
| Kestra Medical Technologies (KMTS) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.643B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.545B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.512B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.282B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 78.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.93 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Quanterix (QTRX) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.240B | 10.90 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.236B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.15 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.76 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.25 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |